Phase I – BIRDYE Study
Title: Validation of Uptake of a VEGF-targeted Optical Fluorescent Imaging Tracer in Surgical Specimens of Breast Cancer and Application of Pre- and Intra-operative Human Molecular Fluorescence Imaging Techniques. A Multicenter Feasibility Study
Status: Completed
https://clinicaltrials.gov/ct2/show/NCT01508572

Phase II – MARGIN Study
Title:  Phase II, Open-Label Study to Evaluate Safety and Explore Efficacy of Escalating Doses of Bevacizumab-IRDye800CW as an Optical Imaging Agent to Detect Cancer Tissue Delineation during Tumor Resection Surgery in Patients with Breast Cancer
Status: Recruiting
https://clinicaltrials.gov/ct2/show/NCT02583568

Phase II – PENGUIN Study
Title:  Intraoperative Detection of Cancer Tissue in Pancreatic Adenocarcinoma Using a VEGF-targeted Optical Fluorescent Imaging Tracer, A Multicentre Feasibility Dose Escalation Study
Status: Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT02583568

Phase I – Hi-light Study
Title:  Intraoperative detection of tumor tissue in peritoneal carcinomatosis of colorectal origin using a VEGF-­‐targeted Optical Fluorescent Imaging Tracer. A single center pilot study
Status: Closed
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4632

Phase I – Endo-Light study
Title: Determine the feasibility of detecting endometriosis during surgery using a molecular targeted fluorescent imaging tracer
Status: pending